(VIANEWS) – ELIS (ELIS.PA), NAVAMEDIC (NAVA.OL), ASML HOLDING (ASML.AS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ELIS (ELIS.PA)
77.2% sales growth and 5.03% return on equity
Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinal, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is based in Saint-Cloud, France.
Earnings Per Share
As for profitability, ELIS has a trailing twelve months EPS of €0.02.
PE Ratio
ELIS has a trailing twelve months price to earnings ratio of 922.78. Meaning, the purchaser of the share is investing €922.78 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.03%.
Moving Average
ELIS’s value is higher than its 50-day moving average of €15.45 and way higher than its 200-day moving average of €13.49.
Yearly Top and Bottom Value
ELIS’s stock is valued at €16.61 at 11:20 EST, below its 52-week high of €17.07 and way higher than its 52-week low of €10.23.
Sales Growth
ELIS’s sales growth for the next quarter is 77.2%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 25, 2022, the estimated forward annual dividend rate is 0.37 and the estimated forward annual dividend yield is 2.23%.
More news about ELIS.
2. NAVAMEDIC (NAVA.OL)
72.2% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr-1.14.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Volume
Today’s last reported volume for NAVAMEDIC is 3604 which is 85.27% below its average volume of 24481.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr41.60 at 11:20 EST, below its 52-week high of kr42.00 and way higher than its 52-week low of kr25.00.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.6%, now sitting on 382.14M for the twelve trailing months.
More news about NAVAMEDIC.
3. ASML HOLDING (ASML.AS)
17.9% sales growth and 59.35% return on equity
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to assess the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and lithography process and control software solutions; and refurbishes and upgrades older lithography systems, as well as offers customer support and associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Earnings Per Share
As for profitability, ASML HOLDING has a trailing twelve months EPS of €14.63.
PE Ratio
ASML HOLDING has a trailing twelve months price to earnings ratio of 41.26. Meaning, the purchaser of the share is investing €41.26 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 59.35%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 137.6% and 23.2%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 9.5 and the estimated forward annual dividend yield is 1.62%.
Moving Average
ASML HOLDING’s worth is higher than its 50-day moving average of €600.79 and way higher than its 200-day moving average of €526.23.
Volume
Today’s last reported volume for ASML HOLDING is 207631 which is 70.6% below its average volume of 706238.
More news about ASML HOLDING.
4. PROTECTOR FORSIKRG (PROT.OL)
16.2% sales growth and 24.06% return on equity
Protector Forsikring ASA, a general insurance company, provides various insurance products to the commercial and public sectors, and the affinity insurance markets in Norway, Denmark, Sweden, the United Kingdom, and Finland. It operates in Commercial Lines of Business and Public Lines of Business segments. The company offers personal, motor, property, liability, and change of ownership insurance. It sells its products to non-marine industries through insurance brokers. Protector Forsikring ASA was founded in 2003 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, PROTECTOR FORSIKRG has a trailing twelve months EPS of kr23.84.
PE Ratio
PROTECTOR FORSIKRG has a trailing twelve months price to earnings ratio of 5.68. Meaning, the purchaser of the share is investing kr5.68 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.06%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 8, 2023, the estimated forward annual dividend rate is 7 and the estimated forward annual dividend yield is 4.78%.
More news about PROTECTOR FORSIKRG.
5. ROBERTET (RBT.PA)
14.1% sales growth and 14.34% return on equity
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in three segments: Raw materials, Fragrances, and Flavors. It also produces organic essential oils and active ingredients. The company operates in North America, Europe, the Asia Pacific, South America, Caribbean, Africa, and the Middle East. Robertet SA was founded in 1850 and is headquartered in Grasse, France.
Earnings Per Share
As for profitability, ROBERTET has a trailing twelve months EPS of €21.87.
PE Ratio
ROBERTET has a trailing twelve months price to earnings ratio of 39.6. Meaning, the purchaser of the share is investing €39.6 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.
More news about ROBERTET.
